Global Epidemiology of Campylobacter Infection
Citations
925 citations
306 citations
Cites background from "Global Epidemiology of Campylobacte..."
...…and it was proved that AgNPs are effective against multidrug resistant bacteria such as multidrug resistant E. coli (Paredes et al., 2014; Kar et al., 2016), multidrug resistant strain of Pseudomonas aeruginosa (Durairaj et al., 2012), methicillin-resistant Staphylococcus aureus (MRSA)…...
[...]
296 citations
284 citations
246 citations
Cites background from "Global Epidemiology of Campylobacte..."
...could cause symptoms associated with campylobacteriosis, and 9 × 104 bacteria is considered the optimum infective dose [27]....
[...]
...Symptoms disappear within 5–7 days [27,51]....
[...]
...This movement is possible due to a single, polar flagellum positioned on one or both ends of the cell [27,28]....
[...]
...Possible complications include: peripheral neuropathies, including the Guillain–Barré Syndrome (GBS, neurological disorder characterised by weakness of limbs, possible involvement of respiratory muscles, anaemia, and sensory loss); reactive arthritis (REA, involving knees and ankles, occurring about a month after infection and developing for as long as 5 years); and functional intestinal disorders, including irritable bowel syndrome (IBS) [27,46,52,53]....
[...]
References
29 citations
"Global Epidemiology of Campylobacte..." refers background in this paper
...Consistently, a study conducted between 2007 and 2009 showed that of 99 hospitalized children with gastroenteritis reported in a hospital in Nahariya, Israel, 61% were positive for Campylobacter species, followed by Shigella (24...
[...]
...For example, the annual incidence of campylobacteriosis in Israel increased from 31.04 cases per 100,000 population in 1999 to 90.99 cases per 100,000 population in 2010, with children under the age of 2 years having the highest incidence (356.12 cases per 100,000 population) (67)....
[...]
...The latest information on the global epidemiology of campylobacteriosis from the literature is shown, including data from the United Kingdom (47), Denmark (11), Germany (49), Norway (424), Poland (25, 50, 425), the Netherlands (51), Israel (67), China (60, 61), Japan (26), India (63–65), Australia (69), New Zealand (73), Madagascar (78), Malawi (77), Kenya (79, 426), Guatemala (41), Peru (427), Mexico (428), the United States (10 sites within The Food-Borne Diseases Active Surveillance Network) (34), and Canada (37–39)....
[...]
29 citations
29 citations
29 citations
29 citations